Home > Boards > Stock Clubs > Penny Flippers > ATM SIMULATOR

REPR -- profitable, cash-rich, rapidly growing, recession-proof, tiny

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Rawnoc Member Profile
Followed By 1,153
Posts 139,854
Boards Moderated 4
Alias Born 08/27/03
160x600 placeholder
Rawnoc   Thursday, 08/27/09 09:44:09 AM
Re: None
Post # of 11062 
REPR -- profitable, cash-rich, rapidly growing, recession-proof, tiny float OS & market cap with a juicy FDA approval pending any week...

Management is so confident of continued much higher profits than last quarter going forward that they have set aside a "deferred tax asset" in the balance sheet "based the valuation allowance calculations on the prospect of future profitability"

Products are recession-proof with no direct competition with sales rapidly expanding due to a new treatment (Vivaglobin) where their infusion pump is the best, cheapest, safest, and most convenient form of delivery:

Medicare reimbursement for the Freedom60 (their biggest & most exciting revenue-generating product) was increased 20 fold in June of 2007 and is the ONLY infusion pump accepted by Medicare for reimbursement for Subcutaneous Immune Globulin treatment (Vivaglobin):

They are hiring like crazy:

FDA Approval pending and could be announced any day which should help accelerate sales & earnings:

Based on seasonal & cylical patterns as well as their recent hiring and doubling of shifts and landing business with a huge hospital & the pending FDA approval, I suspect REPR is 1 or 2 quarters away from +.02 EPS per quarter or more or an annualized +.08 EPS pace IMO. 10 PE = .80/share, 15 PE = $1.20/share. 20 PE = $1.80/share

REPR Board:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist